Joseph P. Hagan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph P. Hagan
Joseph P. Hagan was last confirmed as CEO at Aurinia Pharmaceuticals Inc. (AUPH) in a filing dated April 18, 2023. Aurinia Pharmaceuticals Inc. reported in an 8-K filed July 3, 2023 that Joseph P. Hagan resigned as director, effective June 29, 2023.
“the Board, following the deliberation process outlined in the Company's Majority Voting Policy, determined to accept the resignations of Dr. Milne and Mr. Hagan effective June 29, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-04-18
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.